Stirling University to Open Campus COVID Vaccination Center | About


A new vaccination center will open on Saturday August 14 at the University of Stirling, allowing the public, students and staff of the University to receive their COVID-19 vaccine.

The facility is being installed in the University’s Pathfoot building and will offer both walk-in and scheduled appointments.

Anyone currently living in Scotland who needs a first or second dose of the vaccine can attend. This includes international students arriving on campus and those who have not yet registered with a general practitioner.

The center will operate seven days a week, 8:30 a.m. to 7:00 p.m., and will have the capacity to deliver up to 600 vaccines per day, increasing immunization capacity across the region. It will be installed alongside existing NHS Forth Valley community vaccination sites.

Pathfoot Building, University of Stirling

Eileen Schofield, University Secretary and Head of COVID Response at Stirling University, said: “Immunization is essential for the protection of our students, staff and our community at large and I am grateful for the work of my fellow academics and the NHS Forth Valley. by creating this center.

“We are proud to be able to host this facility and, in return, support the national effort to get people vaccinated and stop the spread of COVID-19. “

Jillian Taylor, NHS Forth Valley Operations Manager for the Covid-19 Vaccination Program, said: “It’s great to be able to offer a supplemental vaccination clinic at the University of Stirling site, especially for youth who may not have accepted the offer of Anyone 18 years of age or older as of October 31, 2021 can attend this new vaccination clinic or one of the other clinics here in Forth Valley, or n anywhere in Scotland.

“We know that receiving both doses of the vaccine provides maximum protection against the virus, so if it has been eight weeks or more since your first vaccine, please attend your second. Details of local walk-in clinics are available on our website. “


Comments are closed.